A1Cantus vs. Placebo

Part of paid clinical trials in Riverside, California.

Sponsor
University of California, Riverside
Study ID
NCT07585630
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • A1C Drink — DIETARY_SUPPLEMENT
    In the experimental arm, participants will drink the A1C drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.
  • Placebo drink — OTHER
    In the placebo arm, participants will drink the placebo drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.

Study Details

The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.

Key Dates

Start date
Jun 15, 2026
Status verified
May 2026
Primary completion
Dec 15, 2027
Completion
Jun 1, 2028

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Placebo Drink
    The placebo drink will be formulated to closely match the active drink in taste, color and mouthfeel, while removing all active ingredients.
  • Experimental: A1C Drink
    The A1C drink is currently on the market with natural active ingredients.

Primary Outcome Measure

Hemoglobin A1C [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UCR HealthRiversideCalifornia92521
Elizabeth Jacobs, MD, MPP
[email protected]
951-827-8643

Find similar trials in Riverside, CA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
UCR Health· Riverside, CA

Related Studies